study in high risk patients switched from higher doses of other statins to Crestor on the percentage of patients reaching the new LDL-C target goal

Study identifier:NL401142

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

REALISTIC: Protocol for an observational study in high risk patients switched from higher doses of other statins to Crestor on the percentage of patients reaching the new EAS LDL-C target goal

Medical condition

Hypercholesterolemia

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

2650

Study type

Observational

Age

18 Years - 70 Years

Date

Study Start Date: 01 Sept 2004

Primary Completion Date: 01 Feb 2008

Study Completion Date: 01 Feb 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

ALKMAAR, Netherlands

Location

Research Site

ALMELO, Netherlands

Location

Research Site

ALPHEN AAN DEN RIJN, Netherlands

Location

Research Site

AMSTERDAM, Netherlands

Location

Research Site

APELDOORN, Netherlands

Location

Research Site

ASSEN, Netherlands

Location

Research Site

BERGEN OP ZOOM, Netherlands

Location

Research Site

BEVERWIJK, Netherlands

Arms	Assigned Interventions

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1086&filename=CSR-NL401142.pdf
Download
CSR-NL401142.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca BV, Zoetermeer Medical Department CV

+31 79 3632284

Investigators

Principal Investigator

AstraZeneca Netherlands Medical Director

AstraZeneca

study in high risk patients switched from higher doses of other statins to Crestor on the percentage of patients reaching the new LDL-C target goal

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1086&filename=CSR-NL401142.pdf

CSR-NL401142.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator